Ingenus Pharmaceuticals LLC

General

Total Cases12
Active Cases5
Patents1
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
09/12/24
SUMMONS Returned Executed by Ingenus Pharmaceuticals, LLC.Hetero USA, Inc. served on 9/12/2024, answer due 10/3/2024. (Taylor, Daniel) (Entered: 09/12/2024)
09/12/24
Summons Issued as to Hetero Labs Ltd. on 9/11/2024; Hetero Labs Ltd. Unit-VI on 9/11/2024; Hetero USA, Inc. on 9/11/2024. (mpb) (Entered: 09/12/2024)
09/12/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ingenus Pharmaceuticals, LLC. (mpb) (Entered: 09/12/2024)
09/12/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,993,952. (mpb) (Entered: 09/12/2024)
09/12/24
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/31/2024. Date of Expiration of Patent: 2/15/2036.Thirty Month Stay Deadline: 7/31/2027. (mpb) (Entered: 09/12/2024)
09/12/24
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 09/12/2024)
09/12/24
COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Hetero Labs Ltd., Hetero Labs Ltd. Unit-VI, Hetero USA, Inc. ( Filing fee $ 405, receipt number ADEDC-4496159.) - filed by Ingenus Pharmaceuticals, LLC. (Attachments: # 1 Civil Cover Sheet)(mpb) (Entered: 09/12/2024)
08/20/24
MINUTE entry before the Honorable Maria Valdez: This matter has been referred to Judge Valdez for discovery supervision and to conduct a settlement conference. The parties shall file a joint status report on discovery progress by 9/13/24. If they wish to begin the process of scheduling a settlement conference at any time prior to that date, they may notify the Court. Mailed notice (lp, ) (Entered: 08/20/2024)
08/19/24
TRANSCRIPT OF PROCEEDINGS held on 8/16/24 before the Honorable Mary M. Rowland. Video status. Order Number: 49589. Court Reporter Contact Information: Laura Renke, OfficialTranscript@gmail.com, 312.435.6053. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 9/9/2024. Redacted Transcript Deadline set for 9/19/2024. Release of Transcript Restriction set for 11/18/2024. (Renke, Laura) (Entered: 08/19/2024)
08/19/24
NOTICE of Appearance by LAURA E. KRAWCZYK on behalf of EARLE REFINING, LLC (KRAWCZYK, LAURA) (Entered: 08/19/2024)